Alimera Sciences Reports First Quarter 2014 Financial Results

[PR Newswire] – ATLANTA, May 8, 2014 /PRNewswire/ — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic … more

View todays social media effects on ALIM

View the latest stocks trending across Twitter. Click to view dashboard

See who Alimera is hiring next, click here to view